Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 10 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Maize hybrid X05C007
Metal complexes of tetraazamacrocycle derivatives
Elliptic curve-based message authentication code system and method
Goggle box
Reconfigurable harness board
Portable radiographic image capture device, image capture controller, and radiographic image capture system
  Randomly Featured Patents
Low cost flight attachment for modular belts
On-demand auto-tuner for a plant control system
5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors
Safety shield spiking tool and method for spiking high voltage power lines
Device for limiting a working stroke of a hydraulic cylinder
Apparatus and method for correcting for aberrations
Wrapping pipe for a bundle of hollow fibers, method and device for production thereof
By-pass flow catalytic converter
Cloning and recombinant production of vespid venom phospholipases, and immunological therapies based thereon
Portion of light fixture housing